Prime Therapeutics is a Minnesota-based in-house healthcare insurance company that operates as a pharmacy benefit manager (PBM). Its filings show it lobbies Congress on pharmacy and health issues, focusing on PBM transparency and proposals to “delink” PBM rebates or payments, and on legislation such as H.R. 2214 (the Drug Act). It hired Stumptown Strategies and reported about $100,000 in lobbying through five filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BLAIR LARKINS
The latest disclosures for this client.
STUMPTOWN STRATEGIES
Q1STUMPTOWN STRATEGIES
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
STUMPTOWN STRATEGIES
STUMPTOWN STRATEGIES
Q3STUMPTOWN STRATEGIES
Q2STUMPTOWN STRATEGIES
Q1